250 results on '"Tamai, Toshiyuki"'
Search Results
2. Comparison of safety outcomes of anticancer drugs in Japanese and non-Japanese patients in multi-regional clinical trials: meta-analysis of safety profiles
3. Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial
4. Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT StudyBiomarker Analysis Following Lenvatinib in Unresectable HCC
5. Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study
6. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial
7. Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT
8. Analysis of tumor biomarkers in patients (pts) with advanced hepatocellular carcinoma (HCC) from a phase 1b study of E7386, a CREB-binding protein/β-catenin interaction inhibitor, in combination with lenvatinib.
9. Comparison of efficacy outcomes of anticancer drugs between Japanese patients and the overall population
10. Properties of surface layers of polyethylene naphthalate substrates modified by ultraviolet light irradiation for their electroless deposition
11. REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
12. Polydopamine-Coated Solid Silica Nanoparticles Encapsulating IR-783 Dyes: Synthesis and NIR Fluorescent Cell Imaging.
13. Case Note on the Judgment of the Tokyo District Court on September 2, 2015
14. Near-Infrared Dye Immobilized in Porous Silica Layer on Gold Nanorod and Its Fluorescence Enhancement by Strengthened Electromagnetic Field Based on Surface Plasmon Resonance
15. Supplementary Figure 1 from Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma
16. A phase 1 study of E7386, a CREB-binding protein (CBP)/β-catenin interaction inhibitor, in patients (pts) with advanced solid tumors including colorectal cancer: Updated dose-escalation part.
17. Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma
18. 'Fair M&A Guidelines' and MBOs
19. Estimation of uniformity in Schottky contacts between printed Ni electrode and n-GaN by scanning internal photoemission microscopy
20. Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma
21. Abstract CT523: An open-label, multicenter, phase 1b/2 Study of E7386 (Wnt/β-catenin pathway inhibitor) + pembrolizumab in patients with pretreated advanced solid tumors
22. Highly c-axis oriented deposition of zinc oxide on an ITO surface modified by layer-by-layer method
23. Dose Finding of Lenvatinib in Subjects With Advanced Hepatocellular Carcinoma Based on Population Pharmacokinetic and Exposure–Response Analyses
24. Modification of PEN and PET film surfaces by plasma treatment and layer-by-layer assembly of polyelectrolyte multilayer thin films
25. Lenvatinib dose, efficacy, and safety in the treatment of multiple malignancies
26. 'Fair M&A Guidelines' and Freezeout Transactions(2)
27. Helically aligned fused carbon hollow nanospheres with chiral discrimination ability
28. Room-temperature coalescence of Pd nanoparticles with sacrificial templates and sintering agents, and their catalytic activities in the Suzuki coupling reaction
29. A fusion protein N-cadherin-Fc as an artificial extracellular matrix surface for maintenance of stem cell features
30. M&A Transactions and Injunctive Relief
31. Hybrid films prepared from latex particles incorporating metal oxide nanoparticles
32. Surface Modification and Electroless Deposition of Flexible Polymer Substrates
33. Pharmacodynamic Biomarkers Predictive of Survival Benefit with Lenvatinib in Unresectable Hepatocellular Carcinoma: From the Phase III REFLECT Study.
34. Impact of bodyweight (BW)-based starting doses on safety and efficacy of lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC).
35. Room-Temperature Coalescence of Tri-n-Octylphosphine-Oxide-Capped Cu-Ag Core-Shell Nanoparticles: Effect of Sintering Agent and/or Reducing Agent
36. Baseline Liver Function and Subsequent Outcomes in the Phase 3 REFLECT Study of Patients with Unresectable Hepatocellular Carcinoma
37. Printed Silver Electrode for Silicon-based Schottky Barrier Diode: High Rectification Ratio Enabled by Ag/p-Si Interface Exceeds Theoretical Barrier Height
38. Comparison of efficacy outcomes of anticancer drugs between Japanese patients and the overall population
39. Two-Dimensional Characterization of n-GaN Schottky Contacts Printed by Using Ni Nanoink
40. Crystal structure of 7,7′-[(pyridin-2-yl)methylene]bis(5-chloroquinolin-8-ol)
41. Baseline liver function and outcomes in the phase III REFLECT study in patients with unresectable hepatocellular carcinoma (uHCC).
42. Overall Survival and Objective Response in Advanced Unresectable Hepatocellular Carcinoma: A Subanalysis of the REFLECT Study
43. M&A Transactions and Injunctive Relief(2)
44. Generation of polyphenylene radical cations and their cosensitization ability in the 9,10-dicyanoanthracene-sensitized photochemical chain reactions of 1,2-bis(4-methoxyphenyl)cyclopropane
45. Photoinduced electron transfer reactions of organosilicon compounds
46. Photooxygenation of 1,omega-bis(diarylethenyl)alkanes via photoinduced electron-transfer: formation of 1,4-radical cations and its trapping by molecular dioxygen
47. Salt effect of the 9,10-dicyanoanthracene-sensitized photooxygenation of 1,2-diarylcyclopropanes and the photodecomposition of 3,5-diaryl-1,2-dioxolanes
48. Insertion of nitrogen oxide and nitrosonium ion into the cyclopropane ring: a new route to 2-isoxazolines and its mechanistic studies
49. REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset
50. Crystal structure of catena-poly[[[bis(3-oxo-1,3-diphenylprop-1-enolato-κ2 O,O′)zinc(II)]-μ2-tris[4-(pyridin-3-yl)phenyl]amine-κ2 N:N′] tetrahydrofuran monosolvate]
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.